Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
RESEARCH TOOLSreports
Corvus Pharmaceuticals (CRVS) Ownership - Who Owns Corvus Pharmaceuticals?
483 Followers
Corvus Pharmaceuticals (CRVS) Ownership Overview
39.23% Insiders
3.46% Mutual Funds
24.68% Other Institutional Investors
32.64% Public Companies and
Individual Investors
The ownership structure of Corvus Pharmaceuticals (CRVS) stock is a mix of institutional, retail and individual investors. Approximately 28.14% of the company’s stock is owned by Institutional Investors, 39.23% is owned by Insiders and 32.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 07, 2024 | Richard A. Miller President & Ceo,director | Bought | $999307 |
| May 07, 2024 | William Benton Jones Svp, Pharmaceutical Development | Bought | $34600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $680850 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,585,524 | Institution | 2.53% | 2,885,654 | |
| 1,427,524 | Institution | 2.28% | 2,598,094 | |
| 382,500 | Institution | 0.61% | 696,150 | |
| 341,420 | Institution | 0.55% | 621,384 | |
| 220,700 | Institution | 0.35% | 401,674 | |
| 91,401 | Institution | 0.15% | 166,350 | |
| 46,866 | Institution | 0.07% | 85,296 | |
| 40,167 | Institution | 0.06% | 73,104 | |
| 29,109 | Institution | 0.05% | 52,978 | |
| 20,935 | Institution | 0.03% | 38,102 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,427,524 | Institution | 2.28% | 2,598,094 | |
| 341,420 | Institution | 0.55% | 621,384 | |
| 220,700 | Institution | 0.35% | 401,674 | |
| 46,866 | Institution | 0.07% | 85,296 | |
| 40,167 | Institution | 0.06% | 73,104 | |
| 29,109 | Institution | 0.05% | 52,978 | |
| 20,935 | Institution | 0.03% | 38,102 | |
| 15,668 | Institution | 0.03% | 28,516 | |
| 12,000 | Institution | 0.02% | 21,840 | |
| 7,895 | Institution | 0.01% | 14,369 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,156,008 | Institution | 1.85% | 2,496,977 | |
| 429,516 | Institution | 0.69% | 927,755 | |
| 91,401 | Institution | 0.15% | 166,350 | |
| 18,248 | Institution | 0.03% | 32,481 | |
| 2,565 | Institution | <0.01% | 4,566 |
FAQ
Who Owns Corvus Pharmaceuticals Inc (CRVS)?
According to the latest TipRanks data, approximately 24.68% of the company's stock is held by institutional investors, 39.23% is held by insiders, and 32.64% is held by retail investors.
What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.68% of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors.
What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.64% of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors.
Who owns the most shares of Corvus Pharmaceuticals Inc (CRVS)?
Vanguard owns the most shares of Corvus Pharmaceuticals Inc (CRVS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.